A4671 — Permits terminally ill patients to access investigational therapies; allows corporation business tax credit and gross income tax credit for certain investigational therapies available to terminally ill patients.

A4671 — Permits terminally ill patients to access investigational therapies; allows corporation business tax credit and gross income tax credit for certain investigational therapies available to terminally ill patients. · Informed CitizenryThe Act permits terminally ill patients to access investigational therapies and establishes tax credits for manufacturing these therapies. An eligible patient must have a terminal illness (a condit…Open in Informed Citizenry